Your browser doesn't support javascript.
loading
SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
Haagmans, Bart L; Noack, Danny; Okba, Nisreen M A; Li, Wentao; Wang, Chunyan; Bestebroer, Theo; de Vries, Rory; Herfst, Sander; de Meulder, Dennis; Verveer, Elwin; van Run, Peter; Lamers, Mart M; Rijnders, Bart; Rokx, Casper; van Kuppeveld, Frank; Grosveld, Frank; Drabek, Dubravka; Geurts van Kessel, Corine; Koopmans, Marion; Bosch, Berend Jan; Kuiken, Thijs; Rockx, Barry.
Afiliación
  • Haagmans BL; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Noack D; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Okba NMA; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Li W; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • Wang C; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • Bestebroer T; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • de Vries R; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Herfst S; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • de Meulder D; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Verveer E; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Run P; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Lamers MM; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Rijnders B; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Rokx C; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Kuppeveld F; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • Grosveld F; Department of Cell Biology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Drabek D; Harbour BioMed, Rotterdam, the Netherlands.
  • Geurts van Kessel C; Department of Cell Biology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Koopmans M; Harbour BioMed, Rotterdam, the Netherlands.
  • Bosch BJ; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Kuiken T; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Rockx B; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
J Infect Dis ; 223(12): 2020-2028, 2021 06 15.
Article en En | MEDLINE | ID: mdl-34043806
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Replicación Viral / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Pulmón / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Replicación Viral / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Pulmón / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos